Experts discussed challenges and opportunities for dose optimization of cancer treatments at the 2025 AACR-Industry Roundtable.
Cancer health disparities are driven by the compounding of multiple factors, including gaps in research resulting from insufficient representation...
For the sixth time since 2015, researchers, clinicians, drug developers, patient advocates, and other stakeholders convened at the International...
Guest post by Raymond N. DuBois, MD, PhD, FAACR The headlines stunned many medical professionals, cancer patients, and colorectal...
What is cancer, exactly? For the most part, experts agree. The National Cancer Institute defines cancer as “a disease...
Factors such as a dense tumor microenvironment, a lack of precise symptoms, and hard-to-target genetic mutations make pancreatic cancer...
As we unpack our cardigans in anticipation of cooler weather here on the East Coast, we are taking a...
Guest post by Patrick Casey, PhD, and Joanne Ngeow, BMedSci, MBBS, FRCP, MPH From November 7-9, 2022, Singapore will...
Washington, D.C., holds a special place in the history of the American Association for Cancer Research (AACR). In 1907,...
Editor’s Note: Raquel Castellanos is assistant director of Scientific Programs at the American Association for Cancer Research. She and...
In 2008, Robin Evans received a devastating diagnosis: stage 4 metastatic triple-negative breast cancer. This subtype of breast cancer,...